S

Skorpios Trust Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for Skorpios Trust with $53.2M in long positions as of Q3 2025, 100% allocated to Healthcare, and 100% concentrated in top 10 positions.

Portfolio Value
$53.2M
Top 10 Concentration
100%
Top Sector
Healthcare (100%)
US Exposure
100%
Market Cap Focus
Small Cap
Countries
1

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 99.70%HealthcareETF: 0.30%
Healthcare
99.70%
ETF
0.30%

Industry Breakdown

2 industries across all sectors

Biotechnology: 99.68%BiotechnologyETF: 0.32%
Biotechnology
Healthcare
99.68%
ETF
ETF
0.32%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Small Cap ($300M - $2B): 99.68%Small Cap ($300M - $2B)N/A (ETF or Unknown): 0.32%
Small Cap ($300M - $2B)
99.68%
N/A (ETF or Unknown)
0.32%

Portfolio Concentration

Top 10 Holdings %
100.0%
Top 20 Holdings %
100.0%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
100.0%
International
-
Countries
1
United States of America
100.00% ($53.2M)
2 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
15 quarters
Avg. Top 20
15 quarters
Avg. All Positions
15 quarters
Median Holding Period
15 quarters
Persistence Rate
100.0%
Persistent Holdings Weight
100.0%
Persistent Positions
2
Longest Held
Stoke Therapeutics, Inc. Common Stock logo
Stoke Therapeutics, Inc. Common StockSTOK - 15 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
0.000%
Avg. Position Weight
50.00%
Largest Position
Stoke Therapeutics, Inc. Common Stock logo
Stoke Therapeutics, Inc. Common StockSTOK - 99.68%
Largest Ownership Stake
Stoke Therapeutics, Inc. Common Stock logo
Stoke Therapeutics, Inc. Common StockSTOK - 4.12%
Avg. Ownership Stake
4.12%
Ownership Stake >5%
0
Ownership Stake >1%
1

Historical (Since Q4 2021)

Avg. New Position
20.15%
Avg. Ownership Stake
25.83%
Largest Position
Stoke Therapeutics, Inc. Common Stock logo
Stoke Therapeutics, Inc. Common StockSTOK - 99.92% (Q1 2024)
Largest Ownership Stake
Stoke Therapeutics, Inc. Common Stock logo
Stoke Therapeutics, Inc. Common StockSTOK - 39.26% (Q4 2021)

Portfolio Turnover

Current Quarter

Turnover Ratio
22.1%
Value Traded
$11.75M
Positions Added
0
Positions Exited
0

Historical (Since Q4 2021)

Avg. Turnover Ratio
16.8%
Avg. Positions Added
0
Avg. Positions Exited
0
Highest Turnover
67.2%
Q3 2023

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.